Fundamental Analysis of UnitedHealth Group Inc. - Growth / Value Index
UNH - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.181
Tremendous increasing in Book Value last 3 year
Tsr Value Index - Poor Score of 28.12
Price to Earning Ratio is 54.46 and EV to EBITDA is 48.91 suggesting that it is very expensive
Price to Book Ratio of 5.12 suggesting that it is very expensive
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 55.60 | 21.99 | -11.24 % | |
| Price to Book | 5.22 | 2.28 | -53.28 % | 4.17 |
| Price to Sales | 1.91 | 1.32 | -13.87 % | |
| Enterprise Value to EBITDA Multiple | 49.87 | 14.45 | -14.31 % |
UNH - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 8.0
Tremendous increasing trend in Net Profit for last 3 year
Over the last 3 years, the company has achieved Incredible Return on Equity
Company Earning excess return
EBITDA is continuously increasing for last 3 Years
Steady ROA in range of 8 to 12 for last 3 years
Good Return On Capital Employed of 15.30
Good Return on Equity of 17.98% is achieved by the company
Tsr Profitability Index - Very Poor Score of 18.12
EPS decline for last four quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 17.98 | 25.22 | 2.08 % | -1.53 |
| Return On Asset | 5.83 | 8.18 | -0.147 % | -0.496 |
| Net Profit Margin | 3.44 | 6.02 | -2.97 % | -1.41 |
| Operating Profit Margin | 11.51 | 8.71 | -0.737 % | 7.95 |
| EBITDA Margin | 3.55 | 9.78 | 1.20 % | -8.13 |
Highlights
| Market Cap | 482861 M |
| Enterprise Value | 515770 M |
| Price/Book TTM | 5.22 |
| Outstanding Share | 920385 K |
| Float/ Outstanding Share | 99.70% |
| Dividend Yield | 1.44 % |
Share Holding
Guru Numbers
| Price/Graham No | 2.38 |
| Peter Lynch Ratio | 0.228 |
| Piotroski F Score | 8.00 |
| Altman Z Score | 7.12 |
| Sloan Ratio | -0.0244 |
| Peter Lynch Fair Value | 126.41 |
UNH - Growth Highlights
Growth Analysis
Tremendous increasing trend in total sale last 3 year
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 291393 M | 14.64 % | 5.69 % |
| Gross Profit | 90165.00 M | 19.73 % | 4.57 % |
| EBITDA | 10343.00 M | 16.01 % | 193.71 % |
| Net Profit | 10019.00 M | 11.24 % | 125.83 % |
| EPS | 9.44 | 12.66 % | NA |
UNH - Stability Highlights
Stability Analysis
Altman Z Score of 7.02 suggests good Stability
Company financial liquidity has improved
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.705 | -0.406 % | 0.797 |
| Cash Ratio | 0.299 | -52.18 % | |
| Quick Ratio | 1.48 | 0 % | 1.57 |
| Shareholders Equity | 32.43 | -2.18 % | |
| Debt to EBITDA | 1.72 | -6.45 % |
Historical Valuation Ratios of UnitedHealth Group Inc.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of UnitedHealth Group Inc.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of UnitedHealth Group Inc.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of UnitedHealth Group Inc.
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)